{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:58:01Z","timestamp":1775152681594,"version":"3.50.1"},"reference-count":44,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychoactives"],"abstract":"<jats:p>In 2025, Psychoactives continued its clear upward trajectory, strengthening its position as an international, peer-reviewed, open-access journal dedicated to advancing the science of psychoactive substances, spanning pharmacology, clinical psychiatry, toxicology, neuroscience, forensic science, and public health [...]<\/jats:p>","DOI":"10.3390\/psychoactives5020008","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T16:51:02Z","timestamp":1775148662000},"page":"8","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Psychoactives in 2025: Consolidating an Interdisciplinary Platform for Psychoactive Substance Science and Looking to the Future"],"prefix":"10.3390","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7430-6297","authenticated-orcid":false,"given":"Ricardo Jorge","family":"Dinis-Oliveira","sequence":"first","affiliation":[{"name":"Associate Laboratory i4HB\u2014Institute for Health and Bioeconomy, University Institute of Health Sciences\u2014CESPU, 4585-116 Gandra, Portugal"},{"name":"UCIBIO\u2014Research Unit on Applied Molecular Biosciences, Translational Toxicology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116 Gandra, Portugal"},{"name":"Department of Public Health and Forensic Sciences and Medical Education, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal"},{"name":"FOREN\u2014Forensic Science Experts, Dr. M\u00e1rio Moutinho Avenue, no. 33-A, 1400-136 Lisbon, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Soylemez, K.K., de Boo, E.M., Susuzlu, A., and Lusher, J. (2025). Neuroplasticity and Neuro-Generation: The Promise of Psychedelics in Dementia Care. Psychoactives, 4.","DOI":"10.3390\/psychoactives4030031"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Soylemez, K.K., de Boo, E.M., and Lusher, J. (2025). Regulatory Challenges of Integrating Psychedelics into Mental Health Sector. Psychoactives, 4.","DOI":"10.3390\/psychoactives4020011"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Tang, B.L. (2025). Psychedelics for Moral Bioenhancement in Healthy Individuals\u2014A Violation of the Non-Maleficence Principle?. Psychoactives, 4.","DOI":"10.3390\/psychoactives4010005"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"K\u00e4h\u00f6nen, J. (2025). Subjective Effects of Psychedelics Are the Plausible Mechanism of Psychedelic Moral Enhancement Rather than a Risk. Comment on Tang, B.L. Psychedelics for Moral Bioenhancement in Healthy Individuals\u2014A Violation of the Non-Maleficence Principle? Psychoactives 2025, 4, 5. Psychoactives, 4.","DOI":"10.3390\/psychoactives4040043"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/15563650.2023.2212125","article-title":"The clinical toxicology of ketamine","volume":"61","author":"Schep","year":"2023","journal-title":"Clin. Toxicol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Dlestikova, T. (2025). The Legal Perspective on Psilocybin for Medical Use in Czechia: A Key Milestone and the Case for Broader Consideration Beyond the Clinical Setting. Psychoactives, 4.","DOI":"10.3390\/psychoactives4030034"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Durney, P., Paquin, E., Fitzpatrick, G., Lockstein, D., Warrick-Stone, T., Montesi, M., Patel-Francis, S.H., Rashid, J., Vaughan-Ogunlusi, O., and Goodsell, K. (2025). Profound Opioid and Medetomidine Withdrawal: A Case Series and Narrative Review of Available Literature. Psychoactives, 4.","DOI":"10.20944\/preprints202508.0751.v1"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"112711","DOI":"10.1016\/j.forsciint.2025.112711","article-title":"Qualitative medetomidine detection in ante- and post-mortem samples via toxicology surveillance testing, Michigan 2024\u20132025","volume":"378","author":"Vohra","year":"2026","journal-title":"Forensic Sci. Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0278-5846(89)90051-1","article-title":"Medetomidine\u2014A novel alpha 2-adrenoceptor agonist: A review of its pharmacodynamic effects","volume":"13","author":"Scheinin","year":"1989","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1345\/aph.1M310","article-title":"An updated focused review of dexmedetomidine in adults","volume":"43","author":"Gerlach","year":"2009","journal-title":"Ann. Pharmacother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(88)90744-3","article-title":"Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist","volume":"150","author":"Virtanen","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/psychoactives3010009","article-title":"New Choking Epidemic Trends in Psychoactive Drugs: The Zombifying Combination of Fentanyl and Xylazine Cause Overdoses and Little Hope in Rehabilitation","volume":"3","year":"2024","journal-title":"Psychoactives"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0140-6736(19)32231-7","article-title":"New psychoactive substances: Challenges for drug surveillance, control, and public health responses","volume":"394","author":"Peacock","year":"2019","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Akosile, W., McDonald, D., Aghanwa, H., and Ola, B. (2025). A Systematic Review of the Prevalence of Substance Abuse in the South Pacific Region. Psychoactives, 4.","DOI":"10.3390\/psychoactives4040042"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ye, J.-H., Zuo, W., Chaudhry, F., and Chinn, L. (2025). Neuroimmune Mechanisms in Alcohol Use Disorder: Microglial Modulation and Therapeutic Horizons. Psychoactives, 4.","DOI":"10.3390\/psychoactives4030033"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Dinis-Oliveira, R.J. (2025). The Scientific Advances in Psychoactives Versus Artifacts in Amphetamine Analysis. Psychoactives, 4.","DOI":"10.3390\/psychoactives4020012"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"112986","DOI":"10.1016\/j.drugalcdep.2025.112986","article-title":"Exploring drug checking services for people who use drugs: Pre-implementation study","volume":"278","author":"Ludwig","year":"2026","journal-title":"Drug Alcohol Depend."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12640-018-9887-1","article-title":"Identification and Quantification of Cocaine and Active Adulterants in Coca-Paste Seized Samples: Useful Scientific Support to Health Care","volume":"34","author":"Galvalisi","year":"2018","journal-title":"Neurotox. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2174\/1389201018666170710184531","article-title":"Adulteration Practices of Psychoactive Illicit Drugs: An Updated Review","volume":"18","author":"Solimini","year":"2017","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Iacopetta, D., Catalano, A., Aiello, F., Andreu, I., Sinicropi, M.S., and Lentini, G. (2025). Xylazine, a Drug Adulterant Whose Use Is Spreading in the Human Population from the U.S. to the U.K. and All Europe: An Updated Review. Appl. Sci., 15.","DOI":"10.3390\/app15063410"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1007\/s00204-017-1947-4","article-title":"Adverse effects of levamisole in cocaine users: A review and risk assessment","volume":"91","author":"Brunt","year":"2017","journal-title":"Arch. Toxicol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/1874473711205010064","article-title":"Clinical and forensic signs related to cocaine abuse","volume":"5","author":"Carvalho","year":"2012","journal-title":"Curr. Drug Abus. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Dunn, J., Schifano, F., Dudley, E., Arillotta, D., and Guirguis, A. (2025). From Veterinary Medicine to Illicit Drug Supply: Utilising Social Media to Explore the Rising Emergence of Veterinary Medicines in Human Health. Brain Sci., 15.","DOI":"10.3390\/brainsci15020172"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"111777","DOI":"10.1016\/j.forsciint.2023.111777","article-title":"Fentanyl concentrations in ligated femoral blood in the presence and absence of NPS benzodiazepine drugs. A review of over 1250 benzo-dope\/fentanyl toxicity cases in Alberta, Canada","volume":"350","author":"Chatterton","year":"2023","journal-title":"Forensic Sci. Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"103169","DOI":"10.1016\/j.drugpo.2021.103169","article-title":"An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods","volume":"93","author":"Laing","year":"2021","journal-title":"Int. J. Drug Policy"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/dta.2054","article-title":"Chemsex intoxication involving sildenafil as an adulterant of GHB","volume":"9","author":"Pichini","year":"2017","journal-title":"Drug Test. Anal."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jamainternmed.2025.2307","article-title":"The Rapid Spread of a Novel Adulterant in the US Illicit Drug Supply\u2014BTMPS","volume":"185","author":"Zhu","year":"2025","journal-title":"JAMA Intern. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.5811\/westjem.2021.2.46317","article-title":"Severe Vitamin K-dependent Coagulopathy from Rodenticide-contaminated Synthetic Cannabinoids: Emergency Department Presentations","volume":"22","author":"Wright","year":"2021","journal-title":"West. J. Emerg. Med."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Di Trana, A., Berardinelli, D., Montanari, E., Berretta, P., Basile, G., Huestis, M.A., and Busard\u00f2, F.P. (2022). Molecular Insights and Clinical Outcomes of Drugs of Abuse Adulteration: New Trends and New Psychoactive Substances. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232314619"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12954-025-01249-1","article-title":"\u2018Tranq\u2019: Perceptions of xylazine and harm reduction practices among people receiving treatment for substance use disorders","volume":"22","author":"Salwan","year":"2025","journal-title":"Harm Reduct. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e70104","DOI":"10.1111\/dar.70104","article-title":"Management of Opioid Withdrawal Syndrome and Commencement of Opioid Dependence Treatment Following Chronic Use of a Vaping Product Containing Protonitazene: Case Report","volume":"45","author":"Dutkiewicz","year":"2026","journal-title":"Drug Alcohol Rev."},{"key":"ref_32","unstructured":"Skarshaug, L.J., Midttun, L., Krabseth, H.M., Gundersen, P.O.M., Hansen, M., Brekke, M.B., and Frost, J. (2025). Etonitazepyne in counterfeit oxycodone tablets\u2014A fatal case report. J. Anal. Toxicol., ahead of print."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpba.2018.04.016","article-title":"Efficiency of extraction and conversion of pseudoephedrine to methamphetamine from tamper-resistant and non-tamper-resistant formulations","volume":"156","author":"Presley","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.chiabu.2006.06.009","article-title":"Children exposed to methamphetamine use and manufacture","volume":"38","author":"Messina","year":"2014","journal-title":"Child Abus. Negl."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"111816","DOI":"10.1016\/j.forsciint.2023.111816","article-title":"Chemical decontamination of methamphetamine and ephedrine using an activated peroxide-containing cleaning solution","volume":"351","author":"Mayer","year":"2023","journal-title":"Forensic Sci. Int."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"105435","DOI":"10.1016\/j.yrtph.2023.105435","article-title":"Gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4BD), and gamma-butyrolactone (GBL) intoxication: A state-of-the-art review","volume":"142","author":"Dufayet","year":"2023","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_37","first-page":"e1","article-title":"Necrotic Lesions Associated with Desomorphine (\u201cKrokodil\u201d) Drug Abuse: A Systematic Review","volume":"16","author":"Sabeva","year":"2025","journal-title":"J. Oral Maxillofac. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.forsciint.2016.03.034","article-title":"The synthesis and investigation of impurities found in Clandestine Laboratories: Baeyer\u2013Villiger Route Part I; Synthesis of P2P from benzaldehyde and methyl ethyl ketone","volume":"263","author":"Doughty","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.2174\/1381612826666200417154810","article-title":"An Overview of Piperazine Scaffold as Promising Nucleus for Different Therapeutic Targets","volume":"26","author":"Sharma","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Jastrz\u0119bski, M.K., Kaczor, A.A., and Wr\u00f3bel, T.M. (2022). Methods of Lysergic Acid Synthesis-The Key Ergot Alkaloid. Molecules, 27.","DOI":"10.3390\/molecules27217322"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Temple, C., Lin, A., and Hughes, A. (2025). Trends in nitrous oxide abuse and misuse: A 22-year analysis of United States poison center data. Clin. Toxicol., ahead of print.","DOI":"10.1080\/15563650.2025.2596142"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e2522164","DOI":"10.1001\/jamanetworkopen.2025.22164","article-title":"US Nitrous Oxide Mortality","volume":"8","author":"Yockey","year":"2025","journal-title":"JAMA Netw. Open"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/S0140-6736(19)32230-5","article-title":"Responding to global stimulant use: Challenges and opportunities","volume":"394","author":"Farrell","year":"2019","journal-title":"Lancet"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"104179","DOI":"10.1016\/j.drugpo.2023.104179","article-title":"Caring for coca, living with chemicals: Towards ecological harm reduction","volume":"120","author":"Rhodes","year":"2023","journal-title":"Int. J. Drug Policy"}],"container-title":["Psychoactives"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2813-1851\/5\/2\/8\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:20:57Z","timestamp":1775150457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2813-1851\/5\/2\/8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["psychoactives5020008"],"URL":"https:\/\/doi.org\/10.3390\/psychoactives5020008","relation":{},"ISSN":["2813-1851"],"issn-type":[{"value":"2813-1851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}